Owner Duke University

Inventors Stamler, Jonathan S.; Zenn, Michael R.; Toone, Eric J.

Agent Cullens

Pub. Number AU-B-2006252204

Parent 2002365036

Filing date 21 December 2006

Wipo publication date 18 January 2007

Acceptance publication date 8 July 2010

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61B 1/00 (2006.01) Diagnosis

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/04 (2006.01) - Nitro compounds

A61K 31/095 (2006.01) - Sulfur, selenium or tellurium compounds, e.g. thiols

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/724 (2006.01)

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/04 (2006.01) Medicinal preparations containing inorganic active ingredients - Sulfur, selenium or tellurium

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups